vTv Therapeutics reports positive topline data from Phase II trial of TTP273 to treat Type 2 diabetes

US-based clinical-stage biopharmaceutical company vTv Therapeutics has reported positive topline results from its Phase II trial of TTP273 to treat Type 2 diabetes.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news